Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study
Recruiting
Observational Study
Bile Duct Stones
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 340 (estimated)
- Sponsor
- Oslo University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The BILNOR study is a prospective multicenter observational study evaluating how common bile duct stones are best managed in patients undergoing cholecystectomy. The study focuses particularly on transcystic laparoscopic common bile duct exploration (LCBDE) and assesses stone clearance, technical success, complications, and health-economic outcomes in routine clinical practice. A secondary aim is …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Age over 18 years
* Preoperatively image proven choledocholithiasis or bile duct sludge (US / CT / MRI)
* ≤ 8 mm size
* ≤ 5 stones
* Not proximal bile duct stones
* Planned cholecystectomy with intraoperative bile duct clearance (LCBDE or intraoperative ERCP)
Exclusion…
Contacts